Immunotherapy in Combination with Chemoradiation in Patients with Advanced Solid Tumors

Trial Identifier: D933BC00001
Sponsor: AstraZeneca
NCTID:: NCT03509012
Start Date: May 2018
Primary Completion Date: December 2020
Study Completion Date: December 2024
Condition: Lung Cancer; Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
ES Badalona, ES, 08916
ES Madrid, ES, 28007
ES Málaga, ES, 29010
JP Koto-ku, JP, 135-8550
JP Sunto-gun, JP, 411-8777
KR Seoul, KR, 03722
KR Seoul, KR, 06351
KR Seoul, KR, 05505
KR Seoul, KR, 03080
TW Taichung, TW, 40705
TW Taipei, TW, 10002
TW Taipei, TW, 112
TW Taoyuan City, TW, 333
US, AZ Tucson, AZ, US, 85719
US, CO Aurora, CO, US, 80045
US, TX Houston, TX, US, 77090